Innovita Biological Technology Co., Ltd. (SHA:688253)

Market Cap	6.03B +19.9%
Revenue (ttm)	422.03M -32.1%
Net Income	146.04M -40.8%
EPS	1.07 -40.9%
Shares Out	134.87M
PE Ratio	41.76
Forward PE	35.46
Dividend	0.56 (1.25%)
Ex-Dividend Date	n/a

Volume	2,629,919
Average Volume	2,015,750
Open	44.88
Previous Close	44.81
Day's Range	43.61 - 45.89
52-Week Range	29.82 - 45.89
Beta	0.85
RSI	69.72
Earnings Date	Apr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 558
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688253

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 146.04 million, a decrease of -40.84%.